Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aditya Birla Group to invest $500 million in Vodafone Idea as revival signal strengthens
Aditya Birla Group is injecting ₹4,730 crore into Vodafone Idea (Vi) through a preferential allotment, bolstering the telecom operator's financial standing. This capital infusion follows Kumar Mangalam Birla's return as chairman and aims to support Vi's efforts to compete with rivals Reliance Jio and Bharti Airtel.
Vodafone Idea Fundraising: Aditya Birla Group Commits $500M Infusion
The Average Revenue Per User increased to Rs Rs. 190 from Rs. 175.
See long-term opportunity in auto parts, aerospace and chemicals: AB Sun Life AMC’s Harish Krishnan
Harish Krishnan of Aditya Birla Sun Life AMC said the rupee’s sharp fall may be nearing its final phase as the government and RBI step up stabilisation measures. He highlighted engineering exports, chemicals, aerospace and IT services as long-term investment themes, while cautioning that margin pressure from rising input costs could continue over the next two quarters.
Exclusive: Promoter-backed fund raise on cards for AB Capital
Source told CNBC-TV18 that Aditya Birla Capital may soon raise ₹4000-₹5000 crore via preferential issue and QIP with promoter and institutional participation. Vodafone Idea to also consider fundraise on May 16.
ET Graphics: Auto industry opens FY27 in top gear despite geopolitical tensions
India’s automobile industry began FY27 on a strong footing, with robust vehicle sales across segments despite ongoing geopolitical uncertainties and global economic concerns. Strong consumer demand, improved rural sentiment and continued momentum in passenger and two-wheeler categories helped automakers post healthy growth at the start of the new financial year.
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27
Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business pressures. However, operations in India, Europe, and emerging markets show healthy growth. New launches like Semaglutide and Abatacept are expected to drive future expansion. Margins are set to improve with better product mix and cost controls.
Aditya Birla group, KKR left in race for Sprng Energy
Aditya Birla Group and KKR are vying to buy Shell's renewable energy firm Sprng Energy. Binding financial bids are in, and Shell will negotiate with the top two contenders next week. India's National Investment and Infrastructure Fund and Actis are out of the running. The deal could be worth around $2 billion. Shell is reviewing strategic options for Sprng Energy.
Aditya Birla Health bets on wellness incentives to improve claims ratios
Aditya Birla Health wants to reward healthier customers, nudge those on the edge to be more consistent, and, lastly, intervene with high-risk customers to help them manage their health.
Aditya Birla Capital allots 2.72 lakh equity shares under ESOP
R R Kabel stock price zooms 46% in 1 month; hits new high in weak market
The W&C business remained the key growth driver, delivering strong growth across domestic and export markets with healthy profitability despite volatility and challenges due to recent global conflicts
Jyothy Labs Ltd leads losers in 'A' group
ABB India Ltd, Kalyan Jewellers India Ltd, Senco Gold Ltd and Aditya Birla Real Estate Ltd are among the other losers in the BSE's 'A' group today, 11 May 2026.
Aditya Birla Fashion & Retail stock: India’s branded apparel player eyes growth amid rising consum - AD HOC NEWS
Aditya Birla Fashion & Retail stock: India’s branded apparel player eyes growth amid rising consumAD HOC NEWS